Brief: Hungary's Richter signs letter of intent with Mithra for commercialisation of Donesta

Richter Gedeon Vegyeszeti Gyar Nyrt

20/12/2022 06:39

Dec 20 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
 GDRB.BU  SAYS:
    * IT HAS SIGNED A BINDING LETTER OF INTENT WITH MITHRA
PHARMACEUTICALS FOR COMMERCIALISATION OF PRODUCT DONESTA
    * DONESTA IS AN ESTETROL-BASED PRODUCT CANDIDATE FOR HORMONE
REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN
    * TERRITORIES COVERED BY THE AGREEMENT ARE EUROPE INCLUDING
RUSSIA
AND CIS COUNTRIES, LATIN AMERICA, AUSTRALIA AND NEW ZEALAND
    * PARTIES INTEND TO FINALISE THEIR PARTNERSHIP IN AN
AGREEMENT IN
Q1 2023
    * UNDER THE TERMS OF THE AGREEMENT MITHRA IS ELIGIBLE TO
RECEIVE
EUR 55 IN UPFRONT PAYMENT AS WELL AS EUR 15 MILLION IN
ADDITIONAL MILESTONE PAYMENTS

Source text for Eikon: [ID: https://bse.hu/newkibdata/128822558/RCH221220ER01E.pdf
]
Further company coverage:  GDRB.BU 
 (Reporting by Anita Komuves)
 ((KOMUVES.Anita@thomsonreuters.com;))